HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wassim Y Almawi Selected Research

factor V Leiden

8/2013Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.
9/2009Case-control Study of methylenetetrahydrofolate reductase mutations and hyperhomocysteinemia and risk of stroke.
8/2008Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity.
12/2007A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
8/2006Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon.
4/2006Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. A case-control study.
12/2005Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.
9/2005Factor V G1691A (Leiden) and prothrombin G20210A single-nucleotide polymorphisms in type 2 diabetes mellitus.
9/2005Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
6/2005A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wassim Y Almawi Research Topics

Disease

11Infections
01/2022 - 07/2003
11Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2021 - 04/2015
11Type 2 Diabetes Mellitus (MODY)
10/2019 - 01/2005
11Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2019 - 03/2004
11Sickle Cell Anemia (Hemoglobin S Disease)
09/2015 - 07/2004
11Spontaneous Abortion (Miscarriage)
10/2013 - 09/2005
10Habitual Abortion (Recurrent Miscarriage)
01/2018 - 12/2002
10Hypertension (High Blood Pressure)
05/2013 - 07/2003
8Neoplasms (Cancer)
08/2022 - 03/2002
8Coronary Artery Disease (Coronary Atherosclerosis)
02/2013 - 06/2004
8Genetic Predisposition to Disease (Genetic Predisposition)
10/2009 - 03/2004
7Diabetic Nephropathies (Diabetic Nephropathy)
10/2019 - 01/2007
7Stroke (Strokes)
09/2010 - 07/2007
6Breast Neoplasms (Breast Cancer)
01/2022 - 04/2018
6Obesity
01/2022 - 09/2005
6Ischemic Stroke
09/2010 - 07/2007
6Hyperhomocysteinemia
08/2010 - 05/2004
5Insulin Resistance
01/2021 - 01/2015
5Inflammation (Inflammations)
10/2018 - 10/2009
5Pre-Eclampsia (Preeclampsia)
10/2018 - 03/2016
5Venous Thromboembolism
08/2013 - 06/2004
4Colorectal Neoplasms (Colorectal Cancer)
09/2020 - 10/2018
4Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2017 - 07/2015
4Thrombosis (Thrombus)
02/2009 - 12/2002
4Venous Thrombosis (Deep-Vein Thrombosis)
12/2007 - 12/2002
3Virus Diseases (Viral Diseases)
01/2021 - 07/2003
3Hirsutism
10/2016 - 04/2015
3Activated Protein C Resistance (APC Resistance)
12/2007 - 04/2005
2Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 04/2022
2Infertility (Sterility)
01/2022 - 05/2020
2Disease Progression
01/2021 - 01/2017
2Diabetic Retinopathy (Retinopathy, Diabetic)
05/2020 - 04/2008
2Acute Coronary Syndrome
05/2013 - 07/2011
2Pain (Aches)
09/2011 - 12/2010
2Bacterial Infections (Bacterial Infection)
06/2010 - 07/2003
2Delayed Graft Function
12/2009 - 01/2009
2Atherosclerosis
10/2009 - 01/2009

Drug/Important Bio-Agent (IBA)

15factor V LeidenIBA
08/2013 - 10/2002
12Prothrombin (Factor II)IBA
08/2013 - 10/2002
9Insulin (Novolin)FDA Link
01/2021 - 07/2003
9Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
08/2010 - 05/2004
8Interleukin-10 (Interleukin 10)IBA
01/2022 - 01/2009
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 06/2011
6CholesterolIBA
05/2013 - 04/2008
5Biomarkers (Surrogate Marker)IBA
08/2022 - 12/2015
5Triglycerides (Triacylglycerol)IBA
01/2021 - 07/2007
5HLA-DRB1 Chains (HLA DRB1)IBA
02/2019 - 01/2005
5CytokinesIBA
10/2018 - 01/2009
5Interleukin-6 (Interleukin 6)IBA
11/2017 - 03/2015
5AutoantibodiesIBA
09/2013 - 04/2011
5Human Platelet AntigensIBA
09/2010 - 01/2008
4InterleukinsIBA
10/2018 - 03/2009
4AdiponectinIBA
01/2018 - 08/2012
4Glucose (Dextrose)FDA LinkGeneric
05/2013 - 01/2009
4AntibodiesIBA
08/2012 - 04/2006
4Annexin A5IBA
09/2011 - 04/2006
4Immunoglobulin M (IgM)IBA
09/2011 - 04/2006
4Immunoglobulin G (IgG)IBA
09/2011 - 04/2006
4HLA Antigens (Human Leukocyte Antigens)IBA
06/2011 - 01/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2010 - 02/2008
4HomocysteineIBA
08/2010 - 01/2006
3Sex Hormone-Binding GlobulinIBA
06/2022 - 08/2015
3Progesterone Receptors (Progesterone Receptor)IBA
04/2022 - 04/2019
3Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2013
3Estrogen ReceptorsIBA
05/2020 - 04/2019
3LipidsIBA
10/2019 - 07/2007
3Apolipoproteins E (ApoE)IBA
10/2019 - 07/2007
3ApolipoproteinsIBA
10/2019 - 07/2007
3C-Reactive ProteinIBA
10/2018 - 12/2010
3Testosterone (Sustanon)FDA Link
10/2016 - 04/2015
3Lymphotoxin-alpha (Lymphotoxin)IBA
02/2014 - 02/2008
3plasma protein Z (protein Z)IBA
09/2013 - 05/2011
3AnticoagulantsIBA
07/2011 - 08/2005
3Factor V (Coagulation Factor V)IBA
12/2007 - 09/2005
2MicroRNAs (MicroRNA)IBA
08/2022 - 03/2016
2CD40 Ligand (CD40L)IBA
05/2020 - 10/2016
2Interleukin-17 (Interleukin 17)IBA
01/2020 - 10/2018
2Oral ContraceptivesIBA
01/2020 - 09/2005
2Hormones (Hormone)IBA
01/2020 - 04/2015
2LeptinIBA
04/2019 - 08/2015
2AndrogensIBA
10/2018 - 04/2015
2ReninIBA
10/2018 - 12/2011
2AngiotensinogenIBA
01/2018 - 12/2011
2FSH Receptors (FSH Receptor)IBA
07/2017 - 04/2015
2Genetic Markers (Genetic Marker)IBA
10/2016 - 10/2010
2LDL CholesterolIBA
01/2016 - 07/2007
2Factor VII (Proconvertin)IBA
05/2013 - 02/2013
2AntigensIBA
05/2013 - 06/2011
2Glycoproteins (Glycoprotein)IBA
08/2012 - 04/2006
2Plasminogen Activators (Plasminogen Activator)IBA
02/2010 - 07/2007
2Tissue Plasminogen Activator (Alteplase)FDA Link
02/2010 - 07/2007
2Plasminogen Activator Inhibitor 1IBA
02/2010 - 07/2007
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2009 - 01/2009
2Dichlororibofuranosylbenzimidazole (DRB)IBA
01/2009 - 03/2004
2CreatinineIBA
01/2009 - 07/2003

Therapy/Procedure

5Therapeutics
01/2022 - 07/2003
4Drug Therapy (Chemotherapy)
04/2022 - 04/2019
3Catheters
06/2010 - 07/2003
3Kidney Transplantation
07/2003 - 07/2003
2Length of Stay
12/2009 - 01/2009